Close Menu

NEW YORK – Quest Diagnostics said after the close of the market on Monday that it has priced its public offering of $800 million aggregate principal amount of its 2.95 percent senior notes due in 2030.

In a document filed with the US Securities and Exchange Commission on Monday, the company said it intends to use the net proceeds from the offering to repay at maturity or redeem its $500 million aggregate principal amount of 4.75 percent senior notes and its $300 million aggregate principal amount of 2.50 percent senior notes, both due 2020.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.